Yingwei Zhen
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Mesenchymal stem cell research
- Glioma Diagnosis and Treatment
Papers in
-
- RNA modifications and cancer 4
- RNA Research and Splicing 3
- Ubiquitin and proteasome pathways 2
- Circular RNAs in diseases 2
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 3
- Co-authors
- Anran Wang (1 shared paper)Nan Yang (3 shared papers)Lei Han (6 shared papers)Cheng Wei (4 shared papers)Kai Yu (2 shared papers)Yue Zhong (2 shared papers)Qiang Huang (2 shared papers)Zhiqiang Zhu (1 shared paper)
- Journals
- Cancer Letters (3 papers)Frontiers in Oncology (2 papers)Journal of Immunology Research (1 paper)International Journal of Molecular Medicine (1 paper)Cell Cycle (1 paper)
- Partner nations
- China
In The Last Decade
Yingwei Zhen
19 papers receiving 340 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 130
- Genetics 42
- Molecular Biology 188
- Developmental Neuroscience 10
- Neurology 24
Countries citing papers authored by Yingwei Zhen
This map shows the geographic impact of Yingwei Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingwei Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingwei Zhen more than expected).
Fields of papers citing papers by Yingwei Zhen
This network shows the impact of papers produced by Yingwei Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingwei Zhen. The network helps show where Yingwei Zhen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yingwei Zhen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 51 | |
| 2 | 2018 | 47 | |
| 3 | 2017 | 44 | |
| 4 | 2018 | 35 | |
| 5 | 2019 | 35 | |
| 6 | 2014 | 27 | |
| 7 | 2020 | 22 | |
| 8 | 2022 | 15 | |
| 9 | 2021 | 12 | |
| 10 | 2022 | 10 | |
| 11 | 2020 | 10 | |
| 12 | 2021 | 8 | |
| 13 | 2018 | 8 | |
| 14 | 2022 | 6 | |
| 15 | 2024 | 6 | |
| 16 | 2024 | 4 | |
| 17 | 2021 | 4 | |
| 18 | 2017 | 3 | |
| 19 | Roles of Wnt/β-Catenin Signaling Pathway Regulatory Long Non-Coding RNAs in the Pathogenesis of Non-Small Cell Lung Cancer | 2020 | 1 |
| 20 | 2026 | 0 |
About Yingwei Zhen
Yingwei Zhen is a scholar working on Molecular Biology, Cancer Research, Genetics, Neurology and Epidemiology, having authored 20 papers that have together received 348 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers), RNA Research and Splicing (3 papers), MicroRNA in disease regulation (3 papers), Ubiquitin and proteasome pathways (2 papers), Microtubule and mitosis dynamics (2 papers), Circular RNAs in diseases (2 papers) and Click Chemistry and Applications (1 paper). The work is most often cited by research in Cancer Research (130 citations), Genetics (42 citations), Molecular Biology (188 citations), Developmental Neuroscience (10 citations) and Neurology (24 citations). Yingwei Zhen has collaborated with scholars based in China. Frequent co-authors include Anran Wang, Nan Yang, Lei Han, Cheng Wei, Kai Yu, Yue Zhong, Qiang Huang, Zhiqiang Zhu, Xiangyu Zheng and Xianzhi Liu. Their work appears in journals such as Cancer Letters, Frontiers in Oncology, Journal of Immunology Research, International Journal of Molecular Medicine and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.